Get started
Author

Nagasuryaprasad Kotikalapudi

Observed names: K Nagasuryaprasad, Kotikalapudi Nagasuryaprasad, Nagasuryaprasad K, Nagasuryaprasad K.
Observed institutions: Beth Israel Deaconess Medical Center, Harvard University, University of Hyderabad, Indian Council of Medical Research, National Institute of Nutrition, Osmania University
ORCID: 0000-0003-2126-9052
Observed ORCID: 0000-0003-2126-9052
OpenAlex ID: A5020067902
Obesity, Metabolic Syndrome, and Osteoarthritis—An Updated Review
2023 · Samuel Joshua Pragasam Sampath, Vijayalakshmi Venkatesan, et al. · Current Obesity Reports · 192
Beneficial effects of secretome derived from mesenchymal stem cells with stigmasterol to negate IL-1β-induced inflammation in-vitro using rat chondrocytes—OA management
2021 · Samuel Joshua Pragasam Sampath, Subha Narayan Rath, et al. · Inflammopharmacology · 28
PDF
Design, synthesis, DNA-binding affinity, cytotoxicity, apoptosis, and cell cycle arrest of Ru(II) polypyridyl complexes
2015 · Putta Venkat Reddy, Mallepally Rajender Reddy, et al. · Analytical Biochemistry · 28
Therapeutic efficacy of 6-Gingerol and 6-Shogaol in promoting browning of white adipocytes vis-à-vis enhanced thermogenesis portrayed in high fat milieu
2021 · Samuel Joshua Pragasam Sampath, Swetha Birineni, et al. · Food Bioscience · 24
A novel therapeutic combination of mesenchymal stem cells and stigmasterol to attenuate osteoarthritis in rodent model system— a proof of concept study
2021 · Samuel Joshua Pragasam Sampath, Nagasuryaprasad Kotikalapudi, et al. · Stem Cell Investigation · 22
Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes
2015 · Venkat Reddy Putta, Nagamani Chintakuntla, et al. · Journal of Fluorescence · 21
The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems
2021 · Nagasuryaprasad Kotikalapudi, Samuel Joshua Pragasam Sampath, et al. · Scientific Reports · 15
PDF
Human placental mesenchymal stromal cell therapy restores the cytokine efflux and insulin signaling in the skeletal muscle of obesity-induced type 2 diabetes rat model
2022 · Nagasuryaprasad Kotikalapudi, Samuel Joshua Pragasam Sampath, et al. · Human Cell · 11
Synthesis, Spectral Properties and DFT Calculations of new Ruthenium (II) Polypyridyl Complexes; DNA Binding Affinity and in Vitro Cytotoxicity Activity
2017 · Rajender Reddy Mallepally, Nagamani Chintakuntla, et al. · Journal of Fluorescence · 10
Studies on Photocleavage, DNA Binding, Cytotoxicity, and Docking Studies of Ruthenium(II) Mixed Ligand Complexes
2016 · Yata Praveen Kumar, C. Shobha Devi, et al. · Journal of Fluorescence · 9
Placental mesenchymal stem cells restore glucose and energy homeostasis in obesogenic adipocytes
2022 · Nagasuryaprasad Kotikalapudi, Samuel Joshua Pragasam Sampath, et al. · Cell and Tissue Research · 8
Acute regulation of murine adipose tissue lipolysis and insulin resistance by the TGFβ superfamily protein GDF3
2025 · Nagasuryaprasad Kotikalapudi, Deepti Ramachandran, et al. · Nature Communications · 5
PDF
Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline
2020 · Nagamani Chintakuntla, Venkat Reddy Putta, et al. · Nucleosides Nucleotides & Nucleic Acids · 4
GDF3 is an obesity-induced regulator of TGFβ superfamily signaling
2022 · Deepti Ramachandran, Nagasuryaprasad Kotikalapudi, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Epigenetic mechanisms of hepatocellular carcinoma progression: Potential therapeutic opportunities
2021 · Sathish Kumar Mungamuri, Kotikalapudi Nagasuryaprasad · Elsevier eBooks · 3
Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems
2021 · Nagasuryaprasad Kotikalapudi, Samuel Joshua Pragasam Sampath, et al. · Scientific Reports · 1
PDF
GDF3 is an endogenous antagonist of the ActE-ALK7/ACVR2 pathway in adipocytes
2026 · Nagasuryaprasad Kotikalapudi, Deepti Ramachandran, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Editorial Expression of Concern: Human placental mesenchymal stromal cell therapy restores the cytokine efflux and insulin signaling in the skeletal muscle of obesity-induced type 2 diabetes rat model
2025 · Nagasuryaprasad Kotikalapudi, Samuel Joshua Pragasam Sampath, et al. · Human Cell
PDF
Works count: 19
Citation count: 384
H-index: 9
I10-index: 9
Year
Topic
Type